XM does not provide services to residents of the United States of America.
B
B

Barclays

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

What to expect in 2024: Fed pivot, cooling inflation, easing growth

FACTBOX-What to expect in 2024: Fed pivot, cooling inflation, easing growth Updates with Barclays and BofA's forecasts for S&P 500; Goldman Sachs estimates March 4 (Reuters) - Global growth will likely slow this year, but a dovish tilt in the Federal Reserve's stance has raised hopes for the U.S. economy and brightened the outlook for riskier assets, according to big banks.
B
C
D
E
G
H
J
S
U
U

Revance Therapeutics drops after $100 mln stock offering prices

BUZZ-Revance Therapeutics drops after $100 mln stock offering prices Updates with pricing details ** Shares of Revance Therapeutics RVNC.O down 10.7% at $6.23 on Mon after equity offering prices ** Aesthetic drug maker sells 16 mln shares at $6.25 for $100 mln gross raise with Barclays as sole bookrunner ** Offering price represents 10.5% discount to stock's close on Fri ** Co plans to use net proceeds to advance commercial growth of Daxxify and its RHA collection of dermal fillers, per the pros
B

Revance Therapeutics drops on $100 mln stock offering plans

BUZZ-Revance Therapeutics drops on $100 mln stock offering plans ** Shares of Revance Therapeutics RVNC.O down 7.7% at $6.42 premarket as co looks to raise equity ** Aesthetic drug maker announces $100 mln stock offering with Barclays as sole bookrunner ** Co plans to use net proceeds to advance commercial growth of Daxxify and its RHA collection of dermal fillers, per the prospectus filing ** RVNC shares on Thurs surged 26% to $7.14 after co late Weds posted Q4 rev of $69.8 mln, up 40% yr/yr, t
B

European companies cut jobs as economy sputters

FACTBOX-European companies cut jobs as economy sputters Adds Barry Callebaut, Evonik, Kuehne+Nagel, Roche, Sainsbury, Valmet, Worldline; updates Bosch, Continental March 4 (Reuters) - The highest inflation for decades and the impact of the war in Ukraine have forced companies across Europe into layoffs or hiring freezes. Here are some cuts announced since December: AUTOS * BOSCH: the automotive supplier on Jan.
A
B
B
B
C
D
E
H
K
L
L
N
N
S
S
T
V
V
H
B
J
S

BofA boosts S&P 500 year-end target to 5,400

UPDATE 1-BofA boosts S&P 500 year-end target to 5,400 Adds details from paragraph 2 March 4 (Reuters) - BofA Global Research has lifted its year-end target for the S&P 500 index .SPX to 5,400, from 5,000 earlier, representing an upside of about 5% from current levels. The brokerage has joined peers Barclays , UBS , and Goldman Sachs in predicting the index would finish the year in a range of 5,200 to 5,400. U.S.
B
U

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.